Proof‐of‐concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin

@article{Mason2009ProofofconceptHL,
  title={Proof‐of‐concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin},
  author={B. Mason and J. Light and L. D. Williams and D. Drobes},
  journal={Addiction Biology},
  year={2009},
  volume={14}
}
  • B. Mason, J. Light, +1 author D. Drobes
  • Published 2009
  • Medicine, Psychology
  • Addiction Biology
  • There is a need for safe medications that can effectively support recovery by treating symptoms of protracted abstinence that may precipitate relapse in alcoholics, e.g. craving and disturbances in sleep and mood. This proof‐of‐concept study reports on the effectiveness of gabapentin 1200 mg for attenuating these symptoms in a non‐treatment‐seeking sample of cue‐reactive, alcohol‐dependent individuals. Subjects were 33 paid volunteers with current Diagnostic and Statistical Manual of Mental… CONTINUE READING
    Emerging pharmacotherapies for alcohol use disorder
    19

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 79 REFERENCES
    Naltrexone's effect on cue-elicited craving among alcoholics in treatment.
    180
    Animal models of craving for ethanol.
    33
    Animal models of craving for ethanol.
    102
    Pharmacological treatment of alcohol dependence: a review of the evidence.
    435
    Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men.
    437
    The acute effects of gabapentin in combination with alcohol in heavy drinkers.
    37